Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 39 (CCDC39) is a structural protein localized to the axonemes of motile cilia and flagella. It forms a heterodimer complex with CCDC40, functioning as a molecular ruler responsible for arranging inner dynein arm complexes and the dynein regulatory complex at a precise 96-nm spacing in cilia. This organization is crucial for normal ciliary motility, which underlies physiological functions such as mucociliary clearance in airways, left-right axis determination in embryogenesis, and sperm tail motility. Mutations in CCDC39 disrupt this architecture, resulting in primary ciliary dyskinesia with characteristic respiratory disease, laterality defects, and male infertility. CCDC39 mutations are also notable for causing severe phenotypes due to both motility-dependent and motility-independent cellular defects, including structural loss of multiple ciliary components. There are currently no drugs targeting CCDC39, but it is considered a key gene for molecular diagnosis and may be a candidate for future gene therapies.
None applicable, as no drugs are known to target CCDC39 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 39 (CCDC39).